CTLA4 and cancer: Immunotherapeutic agents such as anti-programmed death-ligand 1 (PD-L1) and anti-cytotoxic T lymphocyte -associated protein 4 (CTLA-4) inhibitors have emerged as revolutionary cancer treatments [7].